(Q36054968)

11 August 2017

Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy (English)

1 reference

11 August 2017

1 reference

B Vadher

1

1 reference

11 August 2017

D L Patterson

series ordinal

2

1 reference

11 August 2017

M Leaning

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

48

1 reference

11 August 2017

1

1 reference

11 August 2017

63-70

1 reference

Evaluation of a decision support system for initiation and control of oral anticoagulation in a randomised trial

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Audit of start of anticoagulation treatment in inpatients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Interactions of warfarin with drugs and food

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Initialization of warfarin dosages using computer modeling

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Flexible induction dose regimen for warfarin and prediction of maintenance dose

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Investigation of patients with abnormal response to warfarin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Bayesian parameter estimation and population pharmacokinetics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Population pharmacokinetics of racemic warfarin in adult patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Evaluation of a Bayesian regression program for predicting warfarin response.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

A system for compartmental modelling and simulation.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Pharmacokinetics and pharmacodynamics of warfarin at steady state

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

THE EFFECT OF THE USE OF DIFFERENT TISSUE EXTRACTS ON ONE-STAGE PROTHROMBIN TIMES.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014877

One-stage Prothrombin Time Survey

23 September 2018

1 reference

12 December 2020

Comparison of the bioavailabilities and anticoagulant activities of two warfarin formulations

1 reference

12 December 2020

International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control

1 reference

12 December 2020

The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements

1 reference

12 December 2020

Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing

1 reference

12 December 2020

Anticoagulation control with warfarin by junior hospital doctors

1 reference

12 December 2020

The reliability of international normalized ratios during short-term oral anticoagulant treatment

1 reference

12 December 2020

Warfarin dosage predictions assisted by the analog computer

1 reference

12 December 2020

Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force

1 reference

12 December 2020

The influence of heparin on the prothrombin time

1 reference

12 December 2020

1 reference

12 December 2020

Which coagulation factors interfere with the one-stage prothrombin time?

1 reference

12 December 2020

Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time

1 reference

12 December 2020

A computerized intervention to improve timing of outpatient follow-up: a multicenter randomized trial in patients treated with warfarin. National Consortium of Anticoagulation Clinics

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00967.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

10383562

1 reference